NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 18,691,045
- Share change
- -1,981,947
- Total reported value
- $55,880,438
- Put/Call ratio
- 95%
- Price per share
- $2.99
- Number of holders
- 46
- Value change
- -$6,382,969
- Number of buys
- 16
- Number of sells
- 25
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.6%
|
6,954,442
|
$24,062,369 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.8%
|
2,115,277
|
$7,318,858 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.73%
|
1,946,651
|
$6,735,411 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.42%
|
1,115,172
|
$3,858,494 | — | 31 Mar 2023 | |
| Artal Group S.A. |
13F
|
Company |
0.32%
|
850,000
|
$2,941,000 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
690,767
|
$2,390,000 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.26%
|
681,341
|
$2,357,440 | — | 31 Mar 2023 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.21%
|
566,650
|
$1,960,609 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.21%
|
560,295
|
$1,939,000 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.2%
|
531,194
|
$1,837,931 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
520,273
|
$1,800,389 | — | 31 Mar 2023 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.18%
|
471,000
|
$1,629,660 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.16%
|
430,406
|
$1,489,205 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
359,120
|
$1,242,555 | — | 31 Mar 2023 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.12%
|
310,499
|
$1,074,327 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
246,500
|
$852,890 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.09%
|
238,695
|
$825,885 | — | 31 Mar 2023 | |
| EDBI Pte Ltd |
13F
|
Company |
0.08%
|
222,136
|
$768,591 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.08%
|
207,808
|
$719,000 | — | 31 Mar 2023 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.06%
|
162,580
|
$562,527 | — | 31 Mar 2023 | |
| Bridgewater Associates, LP |
13F
|
Company |
0.06%
|
151,560
|
$524,398 | — | 31 Mar 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.06%
|
150,923
|
$522,194 | — | 31 Mar 2023 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.05%
|
120,502
|
$417,000 | — | 31 Mar 2023 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.04%
|
114,223
|
$395,212 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
110,307
|
$381,662 | — | 31 Mar 2023 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
106,938
|
$370,005 | — | 31 Mar 2023 | |
| MASO CAPITAL PARTNERS Ltd |
13F
|
Company |
0.04%
|
100,000
|
$346,000 | — | 31 Mar 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.04%
|
96,555
|
$334,000 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.03%
|
87,022
|
$301,096 | — | 31 Mar 2023 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.02%
|
54,674
|
$189,172 | — | 31 Mar 2023 | |
| CAXTON ASSOCIATES LP |
13F
|
Company |
0.02%
|
53,793
|
$186,124 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
53,129
|
$183,826 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
43,913
|
$151,939 | — | 31 Mar 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
35,717
|
$123,581 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
34,768
|
$120,297 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.01%
|
33,500
|
$116,000 | — | 31 Mar 2023 | |
| ETF MANAGERS GROUP, LLC |
13F
|
Company |
0.01%
|
27,396
|
$94,790 | — | 31 Mar 2023 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.01%
|
26,347
|
$91,161 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
25,319
|
$87,604 | — | 31 Mar 2023 | |
| Vident Investment Advisory, LLC |
13F
|
Company |
0.01%
|
20,829
|
$72,068 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.01%
|
17,266
|
$59,740 | — | 31 Mar 2023 | |
| Diametric Capital, LP |
13F
|
Company |
0.01%
|
13,924
|
$48,177 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0%
|
13,033
|
$45,093 | — | 31 Mar 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0%
|
10,579
|
$36,603 | — | 31 Mar 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
6,259
|
$21,656 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
4,688
|
$16,000 | — | 31 Mar 2023 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0%
|
2,284
|
$7,903 | — | 31 Mar 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,647
|
$6,000 | — | 31 Mar 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
1,559
|
$5,000 | — | 31 Mar 2023 | |
| China Universal Asset Management Co., Ltd. |
13F
|
Company |
0%
|
925
|
$3,201 | — | 31 Mar 2023 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q2 2023
As of 30 Jun 2023,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,691,045 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., VANGUARD GROUP INC, BlackRock Inc., Artal Group S.A., BANK OF AMERICA CORP /DE/, JPMORGAN CHASE & CO, Temasek Holdings (Private) Ltd, UBS Group AG, STATE STREET CORP, and MORGAN STANLEY.
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
51
Q2 2023 holders
46
Holder diff
-5
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.